微生物与感染
2024年11月29日 星期五   首页 |  主编心语 |  期刊介绍 |  编委阵容 |  投稿指南 |  出版道德 |  期刊订阅 |  联系我们 | English
微生物与感染  2021, Vol. 16 Issue (4): 270-279    DOI: 10.3969/j.issn.1673-6184.2021.04.007
  综述 本期目录 | 过刊浏览 | 高级检索 |
广谱抗冠状病毒疫苗及抗冠状病毒多肽的研究进展
曹妙,陆路,姜世勃
复旦大学上海医学院基础医学院教育部/卫健委/医科院医学分子病毒学重点实验室, 上海 200032
Broad-spectrum anti-coronavirus vaccines and peptides: combating the emerging and reemerging coronavirus diseases
CAO Miao, LU Lu, JIANG Shibo
Key Laboratory of Medical Molecular Virology(MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China
全文: PDF (2500 KB)   HTML (301)
输出: BibTeX | EndNote (RIS)       背景资料
文章导读  
摘要: 由严重急性呼吸综合征冠状病毒2型(severe acute respiratory syndrome coronavirus 2,SARS-CoV-2)感染引起的2019冠状病毒病(coronavirus disease 2019,COVID-19)暴发,给人类公共卫生安全和全球经济发展造成了严重威胁。疫苗和药物是防治疫情的重要手段,但目前研发的针对冠状病毒的疫苗和药物大多以SARS-CoV-2为靶点,该病毒若发生重大突变或出现新的高致病性冠状病毒,目前研发的有效疫苗或药物可能会无效,而且疫苗和新药的研发往往比较滞后,难以在疫情发生早期投入使用。因此,亟须研发高效、安全、广谱的冠状病毒疫苗和药物,以应对未来可能出现的冠状病毒疫情。本文对广谱冠状病毒疫苗和抗冠状病毒多肽的研究进展进行综述,期望为研发此类疫苗和药物提供参考。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
曹妙
陆路
姜世勃
关键词 广谱冠状病毒2019冠状病毒病疫苗药物    
Abstract:The pandemic of 2019 coronavirus disease (COVID-19) caused by the 2019 novel coronavirus (2019-nCoV), also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed a serious threat to global public health and economic development. Vaccines and antiviral drugs are important means for combating the epidemic. Most of the vaccines and therapeutics currently being developed are specific for SARS-CoV-2, which may become ineffective if the virus makes major mutation(s) or another highly pathogenic coronavirus emerges. Because the development of a vaccine and a new antiviral drug is often lagging behind, it is difficult to put them into use quickly in the early stage of the outbreak. Therefore, it is an urgent need to develop efficient, safe and broad-spectrum anti-coronavirus vaccines and drugs to combat the possible outbreaks of new coronavirus disease in the future. Here we review the progress of research and development of broad-spectrum anti-coronavirus vaccines and peptides, providing our opinions and suggestions on the development of such vaccines and therapeutics.
Key wordsBroad-spectrum    Coronavirus    2019 coronavirus disease    Vaccine    Drug
:  R18  
  R51  
  R9  
基金资助:国家自然科学基金(82041025)
通讯作者: 姜世勃   
引用本文:   
曹妙,陆路,姜世勃. 广谱抗冠状病毒疫苗及抗冠状病毒多肽的研究进展[J]. 微生物与感染, 2021, 16(4): 270-279.
CAO Miao, LU Lu, JIANG Shibo. Broad-spectrum anti-coronavirus vaccines and peptides: combating the emerging and reemerging coronavirus diseases. JOURNAL OF MICROBES AND INFECTIONS, 2021, 16(4): 270-279.
链接本文:  
http://jmi.fudan.edu.cn/CN/10.3969/j.issn.1673-6184.2021.04.007     或     http://jmi.fudan.edu.cn/CN/Y2021/V16/I4/270

版权所有 © 2008 《微生物与感染》编辑部
地址:上海市医学院路138号 邮编:200032
Tel:021-54237633 Fax:021-64434224    E-mail:jmi@fudan.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发  技术支持:support@magtech.com.cn